02834nas a2200373 4500000000100000008004100001100001400042700001200056700001100068700001600079700001000095700001900105700001000124700001200134700001000146700001000156700001100166700001400177700001100191700001100202700001700213700001600230700001200246700001400258700001100272700001400283700001300297700001000310700001000320245019200330250001500522520187200537020005102409 2015 d1 aTandon N.1 aChen H.1 aLiu Z.1 aKrishnan A.1 aWu Y.1 aPrabhakaran D.1 aLi R.1 aZhao X.1 aLi C.1 aLi X.1 aYan L.1 aDunzhu D.1 aAli M.1 aTian M1 aAmarchand R.1 aPeterson E.1 aAjay V.1 aHameed S.1 aCho K.1 aJindal D.1 aRawal I.1 aJi J.1 aXu L.00aA Cluster-Randomized Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India a2015/07/193 a
BACKGROUND: -In rural areas in China and India, cardiovascular disease burden is high but economic and healthcare resources are limited. This study aims to develop and evaluate a simplified cardiovascular management program (SimCard) delivered by community health workers (CHWs) with the aid of a smartphone-based electronic decision support system. METHODS AND RESULTS: -The SimCard study was a yearlong cluster-randomized controlled trial conducted in 47 villages (27 in China and 20 in India). 2,086 'high cardiovascular risk' individuals (aged 40 years or older with self-reported history of coronary heart disease, stroke, diabetes, and/or measured systolic blood pressure >/=160 mmHg) were recruited. Participants in the intervention villages were managed by CHWs through an Android-powered "app" on a monthly basis focusing on two medication use and two lifestyle modifications. Compared with the control group, the intervention group had a 25.5% (P<0.001) higher net increase in the primary outcome of the proportion of patient-reported anti-hypertensive medication use pre-and-post intervention. There were also significant differences in certain secondary outcomes: aspirin use (net difference 17.1%, P<0.001) and systolic blood pressure (-2.7 mmHg, P=0.04). However, no significant changes were observed in the lifestyle factors. The intervention was culturally tailored and country-specific results revealed important differences between the regions. CONCLUSIONS: -The results indicate that the simplified cardiovascular management program improved quality of primary care and clinical outcomes in resource-poor settings in China and India. Larger trials in more places are needed to ascertain potential impacts on mortality and morbidity outcomes. Clinical Trial Registration Information-clinicaltrials.gov. Identifier: NCT01503814.
a1524-4539 (Electronic)